Keele University

About: Keele University is a education organization based out in Newcastle-under-Lyme, United Kingdom. It is known for research contribution in the topics: Population & Stars. The organization has 11318 authors who have published 26323 publications receiving 894671 citations. The organization is also known as: Keele University.

Is Job Satisfaction an Antecedent or a Consequence of Psychological Burnout

Abstract: A modified version of a process model of psychological burnout proposed by Cherniss (1980) was used to study the relationship between job satisfaction and burnout. The research involved a secondary analysis of longitudinal data collected from 245 school-based educators from a single Board of Education. The results showed that negative work setting characteristics and marital dissatisfaction were associated with greater work stressors, which in turn were associated with increased burnout, which in turn resulted in decreased job satisfaction. When the longitudinal design was employed, psychological burnout appeared to have a causal relationship to job satisfaction, not vice versa.

Dating Experiences of Bullies in Early Adolescence

Abstract: In this study, 196 young adolescents who reported that they bullied their peers were identified out of a sample of 1,758 students in Grades 5 through 8. After selecting from the total sample a grou...

Core outcome domains for clinical trials in non-specific low back pain

Abstract: Purpose Inconsistent reporting of outcomes in clinical trials of patients with non-specific low back pain (NSLBP) hinders comparison of findings and the reliability of systematic reviews. A core outcome set (COS) can address this issue as it defines a minimum set of outcomes that should be reported in all clinical trials. In 1998, Deyo et al. recommended a standardized set of outcomes for LBP clinical research. The aim of this study was to update these recommendations by determining which outcome domains should be included in a COS for clinical trials in NSLBP.

High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective.

Abstract: Study design: Systematic literature review for primary data using predefined inclusion, exclusion and validity criteria. Primary outcome measure was standardised neurological examination or neurological function. Secondary outcomes; acute mortality, early morbidity. Objectives: To access the literature available to clinicians systematically and evaluate the evidence for an effect of high dose methylprednisolone (MPSS) on neurological improvement following acute spinal cord injury (ACSI). Methods: Information retrieval was based on Medline search (1966 through December 1999) using the strategy `spinal cord injury' and `methylprednisolone' (or `dexamethasone') with no other restrictions. Primary data publications using high dose steroids given within 12 h following spinal cord injury and reporting outcome measures separately for steroid and non-steroid treated groups were selected. Evaluation followed the guides of Guyatt et al (for the Evidence Based Working Group in Canada). Studies with questionable validity were excluded. Level of evidence and treatment recommendation utilised the Canadian Task Force on the Periodic Health Examination criteria. Experimental spinal cord injury studies on larger animals were included; small mammal experiments were considered beyond evaluation. Results: Three clinical trials and six cohort study publications were found to satisfy the review criteria. The evidence they provide supports `the recommendation that the manoeuvre (high dose methylpredisolone) be excluded from consideration as an intervention for the condition' (acute spinal cord injury). Twelve larger animal publications were detailed. Validity and the functional significance of results was of concern in many. The weight of evidence lay with those studies demonstrating no definite effect of MPSS on functional outcome. In cat experiments with higher level cord damage, deaths in the MPSS treated groups were notable. Conclusion: The evidence produced by this systematic review does not support the use of high dose methylprednisolone in acute spinal cord injury to improve neurological recovery. A deleterious effect on early mortality and morbidity cannot be excluded by this evidence. Spinal Cord (2000) 38, 273–286.